These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
853 related articles for article (PubMed ID: 18035203)
21. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055 [TBL] [Abstract][Full Text] [Related]
22. Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: a single-dose, randomized-sequence, open-label, two-period crossover trial. Yu JY; Song HH; Kim BG; Park HJ; Choi KS; Kwon YE Clin Ther; 2009 Nov; 31(11):2735-43. PubMed ID: 20110015 [TBL] [Abstract][Full Text] [Related]
23. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR; Shah J Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [TBL] [Abstract][Full Text] [Related]
24. A randomized, open-label pharmacokinetic comparison of two oral formulations of fluconazole 150 mg in healthy adult volunteers. Jovanović D; Kilibarda V; Cirić B; Vucinić S; Srnić D; Vehabović M; Potogija N Clin Ther; 2005 Oct; 27(10):1588-95. PubMed ID: 16330294 [TBL] [Abstract][Full Text] [Related]
25. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability and pharmacokinetic properties of two different enteric formulations of esomeprazole in healthy Bangladeshi male volunteers: An open-label, single-dose, randomized-sequence, two-way crossover study. Ullah MA; Shams-Ud-Dowla ; Maruf AA; Azad MA; Shohag MH; Sultana R; Latif AH; Hasnat A Clin Ther; 2010 Jul; 32(7):1419-26. PubMed ID: 20678688 [TBL] [Abstract][Full Text] [Related]
27. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers. Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372 [TBL] [Abstract][Full Text] [Related]
28. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. Di Girolamo G; Czerniuk P; Bertuola R; Keller GA Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421 [TBL] [Abstract][Full Text] [Related]
29. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers. Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related]
31. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers. Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238 [TBL] [Abstract][Full Text] [Related]
32. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults. Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285 [TBL] [Abstract][Full Text] [Related]
33. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study. Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789 [TBL] [Abstract][Full Text] [Related]
34. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects. Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152 [TBL] [Abstract][Full Text] [Related]
35. Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover study. Park JY; Kim KA; Park PW; Suh KH; Lee GS Clin Ther; 2004 Dec; 26(12):2092-101. PubMed ID: 15823773 [TBL] [Abstract][Full Text] [Related]
36. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers. Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
39. Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers. Poo JL; Galán JF; Rosete A; de Lago A; Oliva I; González-de la Parra M; Jiménez P; Burke-Fraga V; Namur S Clin Ther; 2008 Apr; 30(4):693-9. PubMed ID: 18498918 [TBL] [Abstract][Full Text] [Related]
40. Comparative bioavailability of 2 tablet formulations of levodopa/benserazide in healthy, fasting volunteers: a single-dose, randomized-sequence, open-label crossover study. Keller GA; Czerniuk P; Bertuola R; Spatz JG; Assefi AR; Di Girolamo G Clin Ther; 2011 Apr; 33(4):500-10. PubMed ID: 21635995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]